References
- 1. R. L. Siegel, K. D. Miller and A. Jemal, Cancer Statistics, 2017, CA Cancer J. Clin.67 (2017) 7–30; https://doi.org/10.3322/caac.2138710.3322/caac.2138728055103
- 2. L. G. Gomella, Prostate cancer statistics: anything you want them to be, Can. J. Urol.24 (2017) 8603–8604; https://www.canjurol.com/html/free-articles/V24I1_03_FREE_Editorial_Feb17.pdf
- 3. S. Watanabe, T. Suzuki, F. Hara, T. Yasui, N. Uga and A. Naoe, Polyphyllin D, a steroidal saponin in Paris polyphylla, induces apoptosis and necroptosis cell death of neuroblastoma cells, Pediatr. Surg. Int.33 (2017) 713–719; https://doi.org/10.1007/s00383-017-4069-410.1007/s00383-017-4069-428260192
- 4. D. D. Ma, H. X. Lu, L. S. Xu and W. Xiao, Polyphyllin D exerts potent anti-tumour effects on Lewis cancer cells under hypoxic conditions, J. Int. Med. Res.37 (2009) 631–640; https://doi.org/10.1177/14732300090370030510.1177/14732300090370030519589245
- 5. C. Yang, H. Cai and X. Meng, Polyphyllin D induces apoptosis and differentiation in K562 human leukemia cells, Int. Immunopharmacol.36 (2016) 17–22; https://doi.org/10.1016/j.intimp.2016.04.01110.1016/j.intimp.2016.04.01127104314
- 6. E. Al Sawah, D. C. Marchion, Y. Xiong, I. J. Ramirez, F. Abbasi, B. M. Boac, S. H. Bush, N. Bou Zgheib, E. C. McClung, B. R. Khulpateea, A. Berry, A. Hakam, R. M. Wenham, J. M. Lancaster and P. L. Judson, The Chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest, J. Cancer Res. Clin. Oncol.141 (2015) 237–242; https://doi.org/10.1007/s00432-014-1797-x10.1007/s00432-014-1797-x25164128
- 7. L. Wu, Q. Li and Y. Liu, Polyphyllin D induces apoptosis in K562/A02 cells through G2/M phase arrest, J. Pharm. Pharmacol.66 (2014) 713–721; https://doi.org/10.1111/jphp.1218810.1111/jphp.1218824325805
- 8. M. Francois, P. Koopman and M. Beltrame, SoxF genes: Key players in the development of the cardio-vascular system, Int. J. Biochem. Cell Biol.42 (2010) 445–448; https://doi.org/10.1016/j.biocel.2009.08.01710.1016/j.biocel.2009.08.01719733255
- 9. A. Gandillet, A. G. Serrano, S. Pearson, A. L. M. Lie, G. Lacaud and V. Kouskoff, SOX7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification, Blood114 (2009) 4813–4822; https://doi.org/10.1182/blood-2009-06-22629010.1182/blood-2009-06-22629019801444
- 10. T. J. Nelson, A. Chiriac, R. S. Faustino, R. J. Crespo-Diaz, A. Behfar and A. Terzic, Lineage specification of Flk-1+ progenitors is associated with divergent SOX7 expression in cardiopoiesis, Differentiation77 (2009) 248–255; https://doi.org/10.1016/j.diff.2008.10.01210.1016/j.diff.2008.10.012270144319272523
- 11. J. Savage, A. J. Conley, A. Blais and I. S. Skerjanc, SOX15 and SOX7 differentially regulate the myogenic program in P19 cells, Stem Cells27 (2009) 1231–1243; https://doi.org/10.1002/stem.5710.1002/stem.5719489079
- 12. F. Shen, W. S. Cai, Z. Feng, J. L. Li, J. W. Chen, J. Cao and B. Xu, MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression, Tumour Biol.36 (2015) 1913–1921; https://doi.org/10.1007/s13277-014-2794-z10.1007/s13277-014-2794-z25407488
- 13. P. Wang, D. Chen, H. Ma and Y. Li, LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis, Oncol. Targets Ther.10 (2017) 5137–5149; https://doi.org/10.2147/OTT.S14642310.2147/OTT.S146423566184529123412
- 14. Y. Wang, C. Du, N. Zhang, M. Li, Y. Liu, M. Zhao, F. Wang and F. Luo, TGF-beta1 mediates the effects of aspirin on colonic tumor cell proliferation and apoptosis, Oncol. Lett.15 (2018) 5903–5909; https://doi.org/10.3892/ol.2018.804710.3892/ol.2018.8047584067529552221
- 15. J. Wang, S. Zhang, J. Wu, Z. Lu, J. Yang, H. Wu, H. Chen, B. Lin and T. Cao, Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma, Mol. Med. Rep.16 (2017) 499–506; https://doi.org/10.3892/mmr.2017.666010.3892/mmr.2017.6660548209828586005
- 16. M. Yang, G. Cui, M. Ding, W. Yang, Y. Liu, D. Dai and L. Chen, miR-935 promotes gastric cancer cell proliferation by targeting SOX7, Biomed. Pharmacother.79 (2016) 153–158; https://doi.org/10.1016/j.biopha.2016.01.01110.1016/j.biopha.2016.01.01127044823
- 17. L. Guo, D. Zhong, S. Lau, X. Liu, X. Y. Dong, X. Sun, V. W. Yang, P. M. Vertino, C. S. Moreno, V. Varma, J. T. Dong and W. Zhou, Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells, Mol. Cancer Res.6 (2008) 1421–1430; https://doi.org/10.1158/1541-7786.MCR-07-217510.1158/1541-7786.MCR-07-2175265285918819930
- 18. B. Zheng, Q. Wu, K. Zhou, Gang. W. Y. Ren, H. Qi, W. Zhu and G. Weng, Mechanisms and effects of transcription factor SOX7 on the biological activity of the prostate cancer PC-3 cells, J. Wenzhou Medical University.47 (2017) 678–682; https://doi.org/10.3969/j.issn.2095-9400.2017.09.011
- 19. C. Xiuju, W. Zhen and S. Yanchao, SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24, Open Med. (Wars).11 (2016) 133–137; https://doi.org/10.1515/med-2016-002610.1515/med-2016-0026532981328352781
- 20. S. Huang, P. Cui, S. Lin, X. Yao, X. Wang, Y. Ren and G. Weng, The transcription factor creb is involved in sorafenib-inhibited renal cancer cell proliferation, migration and invasion, Acta Pharm.68 (2018) 497–506; https://doi.org/10.2478/acph-2018-003310.2478/acph-2018-003331259702
- 21. W. Liu, R. Ning, R. N. Chen, X. F. Huang, Q. S. Dai, J. H. Hu, Y. W. Wang, L. L. Wu, J. Xiong, G. Hu, Q. L. Guo, J. Yang and H. Wang, Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells, Mol. Carcinog.55 (2016) 440–457; https://doi.org/10.1002/mc.2229310.1002/mc.2229325683703
- 22. M. E. O’Callaghan, E. Raymond, J. Campbell, A. D. Vincent, K. Beckmann, D. Roder, S. Evans, J. McNeil, J. Millar, J. Zalcberg, M. Borg and K. Moretti, Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity, Prostate Cancer Prostatic Dis.20 (2017) 378–388; https://doi.org/10.1038/pcan.2017.2810.1038/pcan.2017.2828585573
- 23. R. C. Ong, J. Lei, R. K. Lee, J. Y. Cheung, K. P. Fung, C. Lin, H. P. Ho, B. Yu, M. Li and S. K. Kong, Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells, Cancer Lett.261 (2008) 158–164; https://doi.org/10.1016/j.canlet.2007.11.00510.1016/j.canlet.2007.11.00518082940
- 24. Y. Luo, J. Hurwitz and J. Massague, Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1, Nature375 (1995) 159–161; https://doi.org/10.1038/375159a010.1038/375159a07753174
- 25. M. P. Swaffer, A. W. Jones, H. R. Flynn, A. P. Snijders and P. Nurse, CDK Substrate Phosphorylation and Ordering the Cell Cycle, Cell.167 (2016) 1750–1761 e1716; https://doi.org/10.1016/j.cell.2016.11.03410.1016/j.cell.2016.11.034516175127984725
- 26. U. Galderisi, F. P. Jori and A. Giordano, Cell cycle regulation and neural differentiation, Oncogene22 (2003) 5208–5219; https://doi.org/10.1038/sj.onc.120655810.1038/sj.onc.120655812910258
- 27. D. Ye, H. Luo, Z. Lai, L. Zou, L. Zhu, J. Mao, T. Jacob, W. Ye, L. Wang and L. Chen, ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells, Sci. Rep.6 (2016) 30276; https://doi.org/10.1038/srep3027610.1038/srep30276495900327451945
- 28. H. Liu, E. Mastriani, Z. Q. Yan, S. Y. Yin, Z. Zeng, H. Wang, Q. H. Li, H. Y. Liu, X. Wang, H. X. Bao, Y. J. Zhou, J. J. Kou, D. Li, T. Li, J. Liu, Y. Liu, L. Yin, L. Qiu, L. Gong and S. L. Liu, SOX7 co-regulates Wnt/beta-catenin signaling with Axin-2: both expressed at low levels in breast cancer, Sci. Rep.6 (2016) 26136; https://doi.org/10.1038/srep2613610.1038/srep26136487056627188720
- 29. D. Chen, J. Li, S. Li, P. Han, N. Li, Y. Wang and S. Du, miR-184 promotes cell proliferation in tongue squamous cell carcinoma by targeting SOX7, Oncol. Lett.16 (2018) 2221–2228; https://doi.org/10.3892/ol.2018.890610.3892/ol.2018.8906603641430008922
- 30. H. Liu, Z. Q. Yan, B. Li, S. Y. Yin, Q. Sun, J. J. Kou, D. Ye, K. Ferns, H. Y. Liu and S. L. Liu, Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/beta-catenin signaling pathway, J, Ovarian Res.7 (2014) 87; https://doi.org/10.1186/s13048-014-0087-110.1186/s13048-014-0087-1417277925297608
- 31. L. Wang, Y. Fan, L. Zhang, L. Li, G. Kuang, C. Luo, C. Li, T. Xiang, Q. Tao, Q. Zhang and J. Ying, Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma, FASEB J.33 (2019) 254–263; https://doi.org/10.1096/fj.201701453RR10.1096/fj.201701453RR29957056
- 32. D. W. Chan, C. S. Mak, T. H. Leung, K. K. Chan and H. Y. Ngan, Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer, Oncotarget.3 (2012) 1546–1556; https://doi.org/10.18632/oncotarget.66710.18632/oncotarget.667368149323295859
- 33. X. Zhou, S. Y. Huang, J. X. Feng, Y. Y. Gao, L. Zhao, J. Lu, B. Q. Huang and Y. Zhang, SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells, World J. Gastroenterol.17 (2011) 4922–4927; https://doi.org/10.3748/wjg.v17.i44.492210.3748/wjg.v17.i44.4922323563722171135
- 34. K. Vermeulen, D. R. V. Bockstaele and Z. N. Berneman, The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Proliferation36 (2003) 131–149; http://dx.doi.org/10.1046/j.1365-2184.2003.00266.x10.1046/j.1365-2184.2003.00266.x649672312814430
- 35. C. Wang, Y. Guo, J. Wang and Z. Min, The suppressive role of SOX7 in hepatocarcinogenesis, PLoS One.9 (2014) e97433; https://doi.org/10.1371/journal.pone.009743310.1371/journal.pone.0097433401631124816720
- 36. X. Liu, J. Li, Z. Yu, J. Li, R. Sun and Q. Kan, miR-935 promotes liver cancer cell proliferation and migration by targeting SOX7, Oncol. Res.25 (2017) 427–435; https://doi.org/10.3727/096504016X1474730020737410.3727/096504016X14747300207374784107127697092